HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Berruyer, M. Articles by Dechavanne, M. Search for Related Content PubMed PubMed Citation Articles by Berruyer, M. Articles by Dechavanne, M.

The Journal of Thoracic and Cardiovascular Surgery, Vol 105, 892-897, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors

M Berruyer, J Amiral, P Ffrench, J Belleville, O Bastien, J Clerc, A Kassir, S Estanove and M Dechavanne
Laboratoire d'Hematologie et INSERM U 331, Hopital Cardio-vasculaire et Pneumologique Louis Pradel, B.P. Lyon Montchat, France.

Brief case histories of three patients aged 58, 38, and 44 years are reported. All underwent cardiovascular operations. Subsequently hemostasis test abnormalities developed between the seventh and eighth postoperative days after exposure to bovine thrombin used with fibrin glue. These were characterized by an increased activated partial thromboplastin time (64 to 147 seconds), prothrombin time (19 to 24 seconds), bovine thrombin time (> 120 seconds) and a markedly reduced factor V level (< 10% in two patients and 16% in the third patient). A patient plasma dilution of 1 in 200 with a normal plasma pool was necessary to correct bovine thrombin time. No fast-acting or progressive inhibitor against factor V could be detected by coagulation tests, and fresh frozen plasma perfusion had no effect. Plasmapheresis was performed preventatively to avoid bleeding, and factor V levels stabilized at around 50% after two to four exchanges. Immunologic studies showed that the inhibitors were directed not only against bovine factors but also against human ones. Therefore factor V decrease could have been the result of rapid clearance from the circulation of complexes formed with a nonneutralizing inhibitor that is not detected by clotting tests. These antibodies were purified by standard methods and immunoaffinity. Fast immunization could be explained by a prior sensitization to bovine thrombin exposure during previous operations. It is suggested that bovine thrombin used with fibrin glue contains small amounts of factor V and may be responsible for these abnormalities. This is in agreement with previous literature reports. However, these described neutralizing factor V inhibitors, which were easily detected.

This article has been cited by other articles:

				D. L. Diesen and J. H. Lawson Bovine Thrombin: History, Use, and Risk in the Surgical Patient Vascular, April 2, 2008; 16(suppl_1): S29 - S36. [Abstract] [Full Text] [PDF]

				The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al. Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86. [Abstract] [Full Text] [PDF]

				E. Tonelli Jr, H. C. de Almeida, and E. A. Bambirra Tissue Adhesives for a Sutureless Fadenoperation: An Experimental Study in a Rabbit Model Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4340 - 4345. [Abstract] [Full Text] [PDF]

				D. R. Fastenau and J. A. McIntyre Immunochemical analysis of polyspecific antibodies in patients exposed to bovine fibrin sealant Ann. Thorac. Surg., June 1, 2000; 69(6): 1867 - 1872. [Abstract] [Full Text] [PDF]

				R. Garcia-Aguado, F. Gil, J. A. Barcia, J. Aznar, F. Hostalet, J. Barbera, and F. Grau Prophylactic Percutaneous Sealing of Lumbar Postdural Puncture Hole with Fibrin Glue to Prevent Cerebrospinal Fluid Leakage in Swine Anesth. Analg., April 1, 2000; 90(4): 894 - 898. [Abstract] [Full Text] [PDF]

				L. K. von Segesser, M. S. Fasnacht, P. R. Vogt, M. Genoni, U. Arbenz, and M. I. Turina Prevention of residual ventricular septal defects with fibrin sealant Ann. Thorac. Surg., September 1, 1995; 60(3): 511 - 516. [Abstract] [PDF]

				L. K. von Segesser, E. Oechslin, R. Jenni, and M. I. Turina Use of glue to avoid formation of perfused recesses in aortic allograft implantation Ann. Thorac. Surg., February 1, 1994; 57(2): 494 - 495. [Abstract] [PDF]